Clinical Trial Update: Valacyclovir in Neonatal Herpes Simplex Virus Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating valacyclovir for neonatal herpes simplex infection has completed, with results posted. The results were posted on 2025-06-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Herpes Simplex Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neonatal Herpes Simplex Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-06-24